Inspiratory Muscle Training in Acute Decompensated Heart Failure
Effects of Inspiratory Muscle Training in Patients With Acute Decompensated Heart Failure
1 other identifier
interventional
28
0 countries
N/A
Brief Summary
Hospitalized patients with acute decompensated heart failure (ADHF) present a high prevalence of inspiratory muscle weakness on admission and discharge. Inspiratory muscle training has been reported as a beneficial approach in chronic heart failure. However, the effects of inspiratory muscle training in hospitalized patients with ADHF have been not known. The aim of this study is to investigate the safety, feasibility, and effects of inspiratory muscle training in hospitalized patients with ADHF.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2023
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 1, 2021
CompletedFirst Posted
Study publicly available on registry
April 8, 2021
CompletedStudy Start
First participant enrolled
January 15, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2024
CompletedNovember 1, 2022
October 1, 2022
3 months
April 1, 2021
October 30, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Maximal Inspiratory Pressure
Maximal inspiratory pressure will be measured by an electronic mouth pressure device (cmH2O)
baseline and hospital discharge, an average of 4 to 10 days
Secondary Outcomes (13)
Adverse events
During the hospitalization, daily, during an average of 4 to 10 days
Recruitment rate
During the hospitalization, daily, during an average of 4 to 10 days
Adherence rate
During the hospitalization, daily, during an average of 4 to 10 days
Retention rate
During the hospitalization, daily, during an average of 4 to 10 days
New York Heart Association Functional Classification
baseline and hospital discharge, an average of 4 to 10 days
- +8 more secondary outcomes
Study Arms (2)
Physical training plus inspiratory muscle training
EXPERIMENTALInspiratory Muscle Training (IMT) will be implemented by using the Power Breathe® device. IMT training will begin with mild to moderate intensity of maximal inspiratory pressure. It will be performed 6 to 10 breaths, 4 sets, and twice daily during the hospitalization when as soon as hemodynamic stability is provided. Physical Training will consist of each functional domain (balance, mobility, strength, and endurance) according to patients' functional levels. These will include static and dynamic balance training, mobility training, functional strength training focused on lower extremities, and endurance training as sustained walking. A daily 30 min session during the hospitalization will be performed with one-on-one supervision when as soon as hemodynamic stability is provided.
Physical training
ACTIVE COMPARATORPhysical Training will consist of each functional domain (balance, mobility, strength, and endurance) according to patients' functional levels. These will include static and dynamic balance training, mobility training, functional strength training focused on lower extremities, and endurance training as sustained walking. A daily 30 min session during the hospitalization will be performed with one-on-one supervision when as soon as hemodynamic stability is provided.
Interventions
Inspiratory muscle training will be performed with an inspiratory muscle training device.
Physical training will be performed with exercise including balance, mobility, functional strength, and endurance.
Eligibility Criteria
You may qualify if:
- The management of a diagnosis of ADHF over 24 hours in a hospital setting
- Hemodynamic stability
- The independence of basic activities of daily life before admission
You may not qualify if:
- Acute myocardial infarction
- Congenital heart disease
- Endocarditis, miyocarditis or pericarditis
- Morbid obesity
- Already participating in cardiac rehabilitation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Sema Savci, Prof
Dokuz Eylul University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Research assistant
Study Record Dates
First Submitted
April 1, 2021
First Posted
April 8, 2021
Study Start
January 15, 2023
Primary Completion
April 1, 2023
Study Completion
April 1, 2024
Last Updated
November 1, 2022
Record last verified: 2022-10
Data Sharing
- IPD Sharing
- Will not share